pac.dog pac.dog / Bills

SB 691An Act amending Titles 35 (Health and Safety), 42 (Judiciary and Judicial Procedure) and 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

Congress · introduced 2025-04-28

Latest action: Referred to JUDICIARY, April 28, 2025

Sponsors

Action timeline

  1. · senate Referred to JUDICIARY, April 28, 2025

Text versions

No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.

Bill text

Printer's No. 0700 · 15,735 characters · source document

Read the full text
PRINTER'S NO.   700

                     THE GENERAL ASSEMBLY OF PENNSYLVANIA



                        SENATE BILL
                        No. 691
                                                Session of
                                                  2025

     INTRODUCED BY LANGERHOLC, STEFANO AND BARTOLOTTA, APRIL 28, 2025

     REFERRED TO JUDICIARY, APRIL 28, 2025


                                      AN ACT
 1   Amending Titles 35 (Health and Safety), 42 (Judiciary and
 2      Judicial Procedure) and 61 (Prisons and Parole) of the
 3      Pennsylvania Consolidated Statutes, establishing the
 4      Nonnarcotic Medication Substance Use Disorder Treatment
 5      Program; in organization and jurisdiction of courts of common
 6      pleas, providing for court assessments for substance use
 7      disorder treatment; in other criminal provisions, further
 8      providing for supervisory relationship to offenders; and, in
 9      Pennsylvania Board of Probation and Parole, further providing
10      for supervisory relationship to offenders.
11      The General Assembly of the Commonwealth of Pennsylvania
12   hereby enacts as follows:
13      Section 1.    Title 35 of the Pennsylvania Consolidated
14   Statutes is amended by adding a chapter to read:
15                                CHAPTER 52C
16                           NONNARCOTIC MEDICATION
17                SUBSTANCE USE DISORDER TREATMENT PROGRAM
18   Sec.
19   52C01.   Definitions.
20   52C02.   Program established.
21   52C03.   Single county authority requirements.
22   52C04.   Use of grant funding.
 1   52C05.   Powers and duties of department.
 2   § 52C01.   Definitions.
 3      The following words and phrases when used in this chapter
 4   shall have the meanings given to them in this section unless the
 5   context clearly indicates otherwise:
 6      "Court."    A court of common pleas of a judicial district, a
 7   problem-solving court or the Philadelphia Municipal Court.
 8      "Department."     The Department of Drug and Alcohol Programs of
 9   the Commonwealth.
10      "Eligible provider."    An organization or entity licensed by
11   the Commonwealth capable of:
12            (1)   assessing an offender to determine if the offender
13      is a candidate to whom medication that prevents a relapse to
14      drug and alcohol dependence should be administered;
15            (2)   providing an individualized treatment plan; and
16            (3)   administering a Federal Drug Administration-approved
17      nonnarcotic medication indicated for use in treating a
18      substance use disorder.
19      "Nonnarcotic medication-assisted substance use disorder
20   treatment."    A substance use disorder treatment that includes
21   the use of a Federal Drug Administration-approved nonnarcotic
22   medication indicated for use in treating a substance use
23   disorder as well as counseling and other substance use disorder
24   treatment measures as deemed clinically appropriate by an
25   eligible provider.
26      "Program."    The Nonnarcotic Medication Substance Use Disorder
27   Treatment Program established under section 52C02 (relating to
28   program established).
29      "Single county authority."    An agency designated by the
30   Department of Health under the act of April 14, 1972 (P.L.221,

20250SB0691PN0700                    - 2 -
 1   No.63), known as the Pennsylvania Drug and Alcohol Abuse Control
 2   Act, to plan and coordinate drug and alcohol prevention,
 3   intervention and treatment services for a geographic area that
 4   may consist of one or more counties.
 5   § 52C02.    Program established.
 6      The Nonnarcotic Medication Substance Use Disorder Treatment
 7   Program is established within the department to increase
 8   opportunities for single county authorities to provide
 9   comprehensive substance use disorder treatment to offenders as
10   may be clinically appropriate through the awarding of grants. To
11   the extent that grant money is available, a single county
12   authority may contract with an eligible provider to make
13   available nonnarcotic medication-assisted substance use disorder
14   treatment to an offender upon whom a court imposes a sentence of
15   confinement, intermediate punishment, an alternative sentence,
16   probation, Accelerated Rehabilitative Disposition or a fine.
17   § 52C03.    Single county authority requirements.
18      In order to be eligible for grant funding under the program,
19   a single county authority shall:
20            (1)   Make an application on a form and in a manner
21      determined by the department.
22            (2)   Enter into a contract with one or more eligible
23      providers as required under section 52C04 (relating to use of
24      grant funding).
25            (3)   Meet any other requirement established by the
26      department.
27   § 52C04.    Use of grant funding.
28      (a)     General rule.--Except as provided for in subsection (b),
29   a single county authority awarded a grant under the program
30   shall contract with an eligible provider that shall:

20250SB0691PN0700                    - 3 -
 1            (1)   Assess each offender to determine if the offender is
 2      a candidate to be administered medication that prevents
 3      relapse to substance use dependence.
 4            (2)   Create an individualized program for each offender
 5      identified under paragraph (1).
 6            (3)   Provide access to and administer nonnarcotic
 7      medication-assisted substance use disorder treatment when
 8      clinically appropriate.
 9            (4)   If determined to not be a candidate for nonnarcotic
10      medication-assisted substance use disorder treatment, provide
11      recommendations to the single county authority as to what
12      type, if any, of medication assisted treatment may be
13      necessary or helpful to the offender and may make a referral
14      to another medication assisted treatment facility that can
15      provide the appropriate treatment.
16            (5)   Provide clinically appropriate inpatient or
17      outpatient services determined necessary to support each
18      individual's treatment plan.
19            (6)   Establish a plan and timetable to collect and
20      disseminate the de-identified personal information to the
21      department relating to relapses and overall effectiveness of
22      the program.
23      (b)     Exception.--If a single county authority is approved by
24   the department as meeting all of the requirements under
25   subsection (a), the single county authority shall be exempt from
26   the requirement to contract with an eligible provider.
27   § 52C05.    Powers and duties of department.
28      (a)     Powers and duties.--The department shall:
29            (1)   Develop a form for single county authorities to
30      apply for grant funding under the program.

20250SB0691PN0700                    - 4 -
 1            (2)   Establish criteria for eligible single county
 2      authorities applying for grant funding under the program.
 3            (3)   Create a form available to eligible providers to be
 4      used to confirm that an offender is eligible for and enrolled
 5      in the program.
 6            (4)   Promulgate rules and regulations as necessary to
 7      implement this chapter.
 8            (5)   Issue a report to the General Assembly relating to
 9      relapses and overall effectiveness of the program no later
10      than one year from the effective date of this section and no
11      later than December 15 of each calendar year thereafter.
12      (b)   Limits on grant awards.--Grant awards shall be at the
13   discretion of the department and shall be limited to amounts
14   annually appropriated to the department for the program.
15      (c)   Statewide substance use disorder treatment assessment
16   coordinator.--To the extent that money is available, the
17   department may appoint a Statewide substance use disorder
18   treatment assessment coordinator. The coordinator may:
19            (1)   Encourage and assist in the establishment of
20      substance use disorder treatment assessments in each judicial
21      district.
22            (2)   Identify sources of funding for substance use
23      disorder treatment assessments, including the availability of
24      grants.
25            (3)   Provide coordination and technical assistance for
26      grant applications.
27            (4)   Develop model guidelines for the administration of
28      substance use disorder treatment assessments.
29            (5)   Establish procedures for monitoring substance use
30      disorder treatment assessments and for evaluating the

20250SB0691PN0700                    - 5 -
 1      effectiveness of substance use disorder treatment
 2      assessments.
 3      (d)   Advisory committee.--The department may establish, from
 4   available money, an interdisciplinary and interbranch advisory
 5   committee to advise and assist the Statewide substance use
 6   disorder treatment assessment coordinator in monitoring and
 7   administrating substance use disorder treatment assessments
 8   Statewide.
 9      Section 2.    Title 42 is amended by adding a section to read:
10   § 918.   Court assessments for substance use disorder treatment.
11      (a)   Establishment.--The court of common pleas of a judicial
12   district, a problem-solving court and the Philadelphia Municipal
13   Court may order an offender charged with a drug-related offense
14   upon whom a court imposes a sentence of confinement,
15   intermediate punishment, an alternative sentence, probation,
16   Accelerated Rehabilitative Disposition or a fine to be assessed
17   by an eligible provider to determine whether the use of a
18   nonnarcotic medication-assisted substance use disorder treatment
19   program may be clinically appropriate for the offender. The
20   court may adopt local rules for substance use disorder treatment
21   assessments. The local rules may not be inconsistent with this
22   section or any rules established by the General Assembly or the
23   Supreme Court.
24      (b)   Failure to participate.--If treatment is determined
25   clinically appropriate by an eligible provider, an offender's
26   failure to participate in a recommended treatment plan as
27   determined by the court-ordered assessment may be considered by
28   the court to be a probation or parole violation under
29   appropriate State or local court rules.
30      (c)   Definitions.--The following words and phrases when used

20250SB0691PN0700                   - 6 -
 1   in this section shall have the meanings given to them in this
 2   subsection unless the context clearly indicates otherwise:
 3      "Drug-related offense."     A criminal offense that a court
 4   determines was motivated by the offender's consumption of or
 5   addiction to alcohol or a controlled substance, counterfeit,
 6   designer drug, drug, immediate precursor or marihuana, as those
 7   terms are defined in the act of April 14, 1972 (P.L.233, No.64),
 8   known as The Controlled Substance, Drug, Device and Cosmetic
 9   Act.
10      "Eligible provider."     An organization or entity licensed by
11   the Commonwealth capable of:
12             (1)   assessing an offender to determine if the offender
13      is a candidate to whom medication that prevents a relapse to
14      drug and alcohol dependence should be administered;
15             (2)   providing an individualized treatment plan; and
16             (3)   administering a Federal Drug Administration-approved
17      nonnarcotic medication indicated for use in treating a
18      substance use disorder.
19      "Nonnarcotic medication-assisted substance use disorder
20   treatment."     A substance use disorder treatment that includes
21   the use of a Federal Drug Administration-approved nonnarcotic
22   medication indicated for use in treating a substance use
23   disorder as well as counseling and other substance use disorder
24   treatment measures as deemed clinically appropriate by an
25   eligible provider.
26      Section 3.     Section 9912 of Title 42 is amended by adding a
27   subsection to read:
28   § 9912.    Supervisory relationship to offenders.
29      * * *
30      (e.2)    Recommendation of offenders for nonnarcotic

20250SB0691PN0700                     - 7 -
 1   medication-assisted substance use disorder treatment.--
 2             (1)   An officer may recommend that an offender under
 3      their supervision be assessed by an eligible provider to
 4      determine whether the use of the program may be clinically
 5      appropriate for the offender as described in section 918
 6      (relating to court assessments for substance use disorder
 7      treatment).
 8             (2)   As used in this subsection, the following words and
 9      phrases shall have the meanings given to them in this
10      paragraph:
11             "Eligible provider."      An organization or entity licensed
12      by the Commonwealth capable of:
13                   (i)    assessing an offender to determine if the
14             offender is a candidate to whom medication that prevents
15             a relapse to drug and alcohol dependence should be
16             administered;
17                   (ii)    providing an individualized treatment plan; and
18                   (iii)    administering a Federal Drug Administration-
19             approved nonnarcotic medication indicated for use in
20             treating a substance use disorder.
21             "Program."      The Nonnarcotic Medication Substance Use
22      Disorder Treatment Program established under 35 Pa.C.S. Ch.
23      52C (relating to Nonnarcotic Medication Substance Use
24      Disorder Treatment Program).
25      * * *
26      Section 4.         Section 6182 of Title 61 is amended by adding a
27   subsection to read:
28   § 6182.    Supervisory relationship to offenders.
29      * * *
30      (e.1)    Recommendation of offenders for nonnarcotic

20250SB0691PN0700                        - 8 -
 1   medication-assisted substance use disorder treatment.--
 2          (1)   An agent may recommend that an offender under their
 3      supervision be assessed by an eligible provider to determine
 4      whether the use of the program may be clinically appropriate
 5      for the offender as described in 42 Pa.C.S. § 918 (relating
 6      to court assessments for substance use disorder treatment).
 7          (2)   As used in this subsection, the following words and
 8      phrases shall have the meanings given to them in this
 9      paragraph:
10          "Eligible provider."      An organization or entity licensed
11      by the Commonwealth capable of:
12                (i)    assessing an offender to determine if the
13          offender is a candidate to whom medication that prevents
14          a relapse to drug and alcohol dependence should be
15          administered;
16                (ii)    providing an individualized treatment plan; and
17                (iii)    administering a Federal Drug Administration-
18          approved nonnarcotic medication indicated for use in
19          treating a substance use disorder.
20          "Program."      The Nonnarcotic Medication Substance Use
21      Disorder Treatment Program established under 35 Pa.C.S. Ch.
22      52C (relating to Nonnarcotic Medication Substance Use
23      Disorder Treatment Program).
24      * * *
25      Section 5.      This act shall take effect in 60 days.




20250SB0691PN0700                     - 9 -

Connected on the graph

Outbound (1)

datetypetoamountrolesource
referred_to_committeePennsylvania Senate Judiciary Committeepa-leg

The full graph

Every typed relationship touching this entity — 1 edge across 1 category. Grouped by what the connection is; the heaviest few are shown, with a link to the full list.

Committees

Referred to committee 1 edge

Who matters

Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.

#MemberRoleSpeechesVotedScore
1Wayne Langerholc (R, state_upper PA-35)sponsor05
2Camera Bartolotta (R, state_upper PA-46)cosponsor01
3Patrick J. Stefano (R, state_upper PA-32)cosponsor01

Predicted vote

Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.

0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)

By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no

Activity

Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.

  1. 2026-05-20 · was referred to Pennsylvania Senate Judiciary Committee · pa-leg

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.